Novartis already received FDA approval of ITVISMA as a gene therapy for the treatment of patients with SMA. Read why NVS ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...
From folk music to abolition and women’s rights, Illinois helped shape American history and culture.
Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.
Synthetic cell SpudCell, the first built from non-living components by University of Minnesota synthetic biologists Kate ...